ABOUT US
Our Mission
Our mission is to develop curative therapies for chronic wound, cancer, and inflammatory disease patients with our multi-target cell and gene therapy platform.
Our Vision
Our goal is to create solid clinical safety and efficacy data in Diabetic Foot Ulcer, other chronic wounds and deadly cancers, and to engage with strategic partners to enable market entry to ensure that this game-changing technology platform benefits millions of patients throughout the world.
SCIENTIFIC ADVISORY BOARDS
DIABETIC FOOT ULCER
VENOUS LEG ULCER
BOARD OF DIRECTORS
Serial Entrepreneur, Board Professional and Biotech Business Advisor
TEAM MEMBERS
MATLEENA PIIROINEN
Drug Safety Officer
SARI ROVAMAA
Executive Assistant